Single-cell transcriptomics has been used for analysis of heterogeneous populations of cells during developmental processes and for analysis of tumor cell heterogeneity. More recently, analysis of pseudotime (PT) dynamics of heterogeneous cell populations has been established as a powerful concept to study developmental processes. Here we perform PT analysis of 3 melanoma short-term cultures with different genetic backgrounds to study specific and concordant properties of PT dynamics of selected cellular programs with impact on melanoma progression. Overall, in our setting of melanoma cells PT dynamics towards higher tumor malignancy appears to be largely driven by cell cycle genes. Single cells of all three short-term cultures show a bipol...
Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to ...
We elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-m...
BACKGROUND: The diversity of functional phenotypes observed within a tumor does not exclusively resu...
Single-cell transcriptomics has been used for analysis of heterogeneous populations of cells during ...
Cellular heterogeneity is regarded as a major factor for treatment response and resistance in a vari...
Metastatic melanoma represents a complex and heterogeneous disease for which there are no therapies ...
Melanoma cells display distinct intrinsic phenotypic states. Here, we seek to characterize the molec...
Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompan...
Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompan...
Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasiv...
The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So ...
The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So ...
Melanoma is one of the most aggressive cancers to date and is marked by a therapy-resistant characte...
Melanoma is one of the most aggressive cancers to date and is marked by a therapy-resistant characte...
Metastatic melanoma is a highly aggressive skin cancer and currently resistant to systemic therapy. ...
Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to ...
We elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-m...
BACKGROUND: The diversity of functional phenotypes observed within a tumor does not exclusively resu...
Single-cell transcriptomics has been used for analysis of heterogeneous populations of cells during ...
Cellular heterogeneity is regarded as a major factor for treatment response and resistance in a vari...
Metastatic melanoma represents a complex and heterogeneous disease for which there are no therapies ...
Melanoma cells display distinct intrinsic phenotypic states. Here, we seek to characterize the molec...
Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompan...
Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompan...
Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasiv...
The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So ...
The mechanisms of adaptive and acquired drug resistance in tumors are not completely understood. So ...
Melanoma is one of the most aggressive cancers to date and is marked by a therapy-resistant characte...
Melanoma is one of the most aggressive cancers to date and is marked by a therapy-resistant characte...
Metastatic melanoma is a highly aggressive skin cancer and currently resistant to systemic therapy. ...
Originally described as interpatient variability, tumour heterogeneity has now been demonstrated to ...
We elucidated genomic and transcriptomic changes that accompany the evolution of melanoma from pre-m...
BACKGROUND: The diversity of functional phenotypes observed within a tumor does not exclusively resu...